Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Associated With Parkinson's Disease or Prodromal or Manifest Lewy Body Dementia

NCT04148391 is registered in ClinicalTrials.gov with Aptinyx as lead sponsor.

NCT NCT04148391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04148391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Associated With Parkinson's Disease or Prodromal or Manifest Lewy Body Dementia
Lead sponsor
Aptinyx
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 14, 2019
Completion date
December 30, 2022
Enrollment
99 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

lewy body disease, mild cognitive impairment, mild dementia, parkinson disease